Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Thoracic radiotherapy for mediastinal nodal recurrence

Katsunori Kagohashi, Hidetsugu Nakayama, Kenji Kagei, Koichi Kurishima, Hiroichi Ishikawa, Hiroaki Satoh

. 2009 ; 52 (1) : 23-25.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07528439

Radiotherapy has been used to treat loco-regional recurrences located at various intra-thoracic sites, but longterm survival of these patients has been rarely observed. We report herein a lung adenocarcinoma patient with locoregional recurrence, who was successfully treated with high-dose radiotherapy. The patient could survive with no evidence of recurrence 5 years after thoracic irradiation. It is probably safe to administrate high-dose radiotherapy for some loco-regional recurrent patients with favorable prognostic factors such as good PS, no body weight loss. Further studies will be required to define a favorable subset of patients most likely to benefit from an aggressive approach.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 17

000      
00000naa 2200000 a 4500
001      
bmc07528439
003      
CZ-PrNML
005      
20111210145408.0
008      
090907s2009 xr e eng||
009      
AR
024    7_
$a 10.14712/18059694.2016.103 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kagohashi, Katsunori
245    10
$a Thoracic radiotherapy for mediastinal nodal recurrence / $c Katsunori Kagohashi, Hidetsugu Nakayama, Kenji Kagei, Koichi Kurishima, Hiroichi Ishikawa, Hiroaki Satoh
314    __
$a Division of Respiratory Medicine, University of Tsukuba, Institute of Clinical Medicine Tsubaka-city
504    __
$a Lit.: 17
520    9_
$a Radiotherapy has been used to treat loco-regional recurrences located at various intra-thoracic sites, but longterm survival of these patients has been rarely observed. We report herein a lung adenocarcinoma patient with locoregional recurrence, who was successfully treated with high-dose radiotherapy. The patient could survive with no evidence of recurrence 5 years after thoracic irradiation. It is probably safe to administrate high-dose radiotherapy for some loco-regional recurrent patients with favorable prognostic factors such as good PS, no body weight loss. Further studies will be required to define a favorable subset of patients most likely to benefit from an aggressive approach.
650    _2
$a adenokarcinom $x radioterapie $x sekundární $7 D000230
650    _2
$a senioři $7 D000368
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x patologie $7 D008175
650    _2
$a lymfatické metastázy $7 D008207
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mediastinum $7 D008482
650    _2
$a lokální recidiva nádoru $x radioterapie $7 D009364
650    _2
$a celková dávka radioterapie $7 D011879
700    1_
$a Nakayama, Hidetsugu
700    1_
$a Kagei, Kenji
700    1_
$a Kurishima, Koichi
700    1_
$a Ishikawa, Hiroichi
700    1_
$a Satoh, Hiroaki
773    0_
$w MED00010947 $t Acta medica (Hradec Králové) $g Roč. 52, č. 1 (2009), s. 23-25 $x 1211-4286
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/am_2009052010023.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 8
990    __
$a 20090907111624 $b ABA008
991    __
$a 20100112093109 $b ABA008
999    __
$a ok $b bmc $g 678983 $s 538942
BAS    __
$a 3
BMC    __
$a 2009 $b 52 $c 1 $d 23-25 $i 1211-4286 $m Acta Medica $x MED00010947
LZP    __
$a 2009-30/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...